YF476: Effects of a Single Dose at 3 Dose Levels on 24-hour Ambulatory Gastric pH Compared With Placebo and Ranitidine in Healthy Volunteers

Trial Profile

YF476: Effects of a Single Dose at 3 Dose Levels on 24-hour Ambulatory Gastric pH Compared With Placebo and Ranitidine in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Apr 2015

At a glance

  • Drugs Netazepide (Primary) ; Ranitidine
  • Indications Reflux oesophagitis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Trio Medicines
  • Most Recent Events

    • 10 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top